(Q44421369)

2 December 2017

Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003) (English)

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

28 December 2023

5

Bart Barlogie

1 reference

2 December 2017

3

Morie A Gertz

1 reference

2 December 2017

Madhav V. Dhodapkar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720140

28 December 2023

Joth L. Jacobson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720140

28 December 2023

John J. Crowley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720140

28 December 2023

language of work or name

1 reference

1 April 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0093775403700815?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

https://api.elsevier.com/content/article/PII:S0093775403700815?httpAccept=text/plain

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

28 December 2023

1 reference

2 December 2017

30

1 reference

2 December 2017

2

1 reference

2 December 2017

220-225

1 reference

Waldenström's macroglobulinemia

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Waldenström's macroglobulinemia: clinical features, complications, and management

28 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

The spectrum of IgM monoclonal gammopathy in 430 cases

28 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

28 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia

28 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine

28 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.

28 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia

28 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Fludarabine treatment in resistant Waldenstrom's macroglobulinemia

28 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Fludarabine therapy in Waldenström's macroglobulinemia

28 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma

28 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity

28 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia

28 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Treatment of Waldenström's macroglobulinemia with rituximab

28 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).

28 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

28 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma

28 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors

28 December 2023

22

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases

28 December 2023

23

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

Treatment of Waldenstrom's macroglobulinemia with thalidomide

28 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50050

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference